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Abstract
Methods: An international database of 1499 laparoscopic liver resections was analysed using multivari-
ate and Kaplan–Meier analysis.
Results: In total, 764 stapler hepatectomies (SH) were compared with 735 electrosurgical resections
(ER). SH was employed in larger tumours (4.5 versus 3.8 cm; P < 0.003) with decreased operative times
(2.6 versus 3.1 h; P < 0.001), blood loss (100 versus 200 cc; P < 0.001) and length of stay (3.0 versus 7.0
days; P < 0.001). SH incurred a trend towards higher complications (16% versus 13%; P = 0.057)
including bile leaks (26/764, 3.4% versus 16/735, 2.2%: P = 0.091). To address group homogeneity, a
subset analysis of lobar resections confirmed the benefits of SH. Kaplan–Meier analysis in non-cirrhotic
and cirrhotic patients confirmed equivalent patient (P = 0.290 and 0.118) and disease-free survival (P =
0.120 and 0.268). Multivariate analysis confirmed the parenchymal transection technique did not increase
the risk of cancer recurrence, whereas tumour size, the presence of cirrhosis and concomitant operations
did.
Conclusions: A SH provides several advantages including: diminished blood loss, transfusion require-
ments and shorter operative times. In spite of the smaller surgical margins in the SH group, equivalent
recurrence and survival rates were observed when matched for parenchyma and extent of resection.
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Introduction
After five decades of innovation, a hepatic resection has become
an accepted surgical procedure for the management of both
benign and malignant tumours. Significant conceptual and tech-
nical changes have resulted in a dramatic improvement in patient
survival. These changes included improved understanding of int-
rahepatic vascular and biliary anatomy, the use of hypovolemic
fluid management, selective vascular control, the introduction of
the laparoscopic approach and varied forms of hepatic parenchy-
mal division. A stapler hepatectomy (SH) is one of these paren-
chymal dissection techniques that have found new utility in
the expansion of a laparoscopic liver resection.1–3 This technique
was first described by Nagorney et al. over 20 years ago.4 Buchler
et al. subsequently popularized this technique in an open liver
resection.5,6
Initial descriptions of a laparoscopic liver resection came from
European centres.7–9 These reports were limited to peripheral
resections, and came with warnings of significant complications
and requirements of expertise in laparoscopic as well as hepato-
biliary surgery. Several early adopters of laparoscopic liver surgery
pursued a SH as an alternative to clip directed dissection.A stapled
right hepatectomy was first reported by O’Rourke et al. and was
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thought to be a safer alternative technique for parenchymal dis-
section.10 Subsequently, several high volume groups adopted this
technique. This study serves to evaluate the benefits and weak-
nesses of SH across a multi-institutional series of groups utilizing
electrosurgery and SH for parenchymal dissection.
Methods
After institutional review board approval for a computerized,
multi-institutional retrospective cohort study, de-identified data
were merged into a central database and examined. An interna-
tional database of 1499 laparoscopic liver resections was estab-
lished and patient outcomes were analysed using univariate, and
multivariate analysis. A 10 centre international cohort of laparo-
scopic liver resections was assembled. Two laparoscopic cohorts
were created: the first cohort was constructed of centres perform-
ing a laparoscopic SH and the second cohort was comprised of
centres performing an electrosurgical hepatectomy. The method
of parenchymal transection was up to the surgeon’s preference;
patients entered in this study had their surgery either performed
at centres using the stapler or an electrosurgical technique. Both
techniques have been well described previously.11–13 An electrosur-
gical resection (ER) included radiofrequency ablation, tissuelink,
ligasure and ultrasonic dissection while for simplicity any patients
that underwent pre-ablation followed by a stapled parenchymal
transection were excluded. The Pringle manoeuvre was routinely
employed in the electrosurgical group but not within the SH
group. Stapled vascular inflow and/or outflow control was permit-
ted in the electrosurgical group as long as staplers were not uti-
lized for parenchymal transection.
Demographic data, pre-operative diagnoses, symptoms, intra-
operative data, patient outcomes and tumour characteristics were
examined. All data are presented as median with ranges. Patients
were analysed on an intent-to-treat basis based on the parenchy-
mal transection technique. Comparisons were performed between
the SH and the electrosurgical hepatectomy group. Continuous
covariates were analysed using the Student’s t-test or the
Wilcoxon–Mann–Whitney test, where appropriate. Categorical
variables were analysed by the chi-squared or Fisher’s exact test,
where appropriate. A univariate analysis was performed to
examine the homogeneity of the two resectional groups. Further
analysis was performed to evaluate the surgical outcomes of each
technique. Analyses included multivariate analysis, chi-square,
Student’s t-test andMann–Whitney test as indicated. To adjust for
malignant disease, the size of the resection and the incidence of
cirrhosis several subset analyses were performed. Subset analysis
was limited to major lobar resections defined as either formal
lobectomies or a trisegmentectomy. Lobar resection data from the
SH and ER group were analysed on the basis of the patients’
underlying parenchyma: cirrhotic versus non-cirrhotic. To assess
the oncological integrity of SH compared with the electrosurgical
approach; Kaplan–Meier analysis was performed for patient and
disease-free survival for all patients with cancer, with additional
subset analysis performed between the cirrhotic and non-
cirrhotic patients. A P-value of 0.05 was considered as statistically
significant.
Cost analysis was performed for SH and ER. Owing to the
international basis of this study, cultural variation is considerable
and this could account for dramatic differences in the length of
stay data. As a result of this confounding variable, it was elected to
perform only an operative cost analysis. This was performed using
cost data for disposable devices and calculated anaesthesia and
operative room cost per unit time ($158 US dollars/minute) with
the primary authors’ expense data used as an index cost. In the SH
group, the primary author’s institutional price was used for the
stapler handles, disposable load, tissuelink, ligasure, an ultrasonic
dissector and hand assist devices; when used this expense was
calculated as the disposable expense.
Results
Analysis of an international database comprised of 1499 laparo-
scopic liver resections identified 764 (51%) SH and 735 (49%) ER.
Patient demographics, tumour characteristics, intra-operative and
post-operative outcomes are presented and analysed for all
patients in Table 1. The incidence of post-operative liver failure
was equivalent between the SH and ER groups (7/764; 0.9% versus
7/735; 1.0%; P = 0.942). The most common complications in the
SH and ER group were biliary (26/764; 3.4% versus 16/735; 2.2%;
P = 0.153), pulmonary (20/764;2.6% versus 13/735; 1.8%; P =
0.262), abdominal fluid collections (8/764; 1.0% versus 8/735;
1.1%; P = 0.937), liver failure (8/764; 1.0% versus 7/735; 1.0%; P =
0.853), post-operative ileus (14/764; 1.8% versus 8/735; 1.1%; P =
0.231), ascites (4/764; 0.5% versus 16/735; 2.2%; P = 0.005), post-
operative hernia (12/764; 1.6% versus 6/735; 0.8%; P = 0.187),
post-operative bleed (8/764; 1.0% versus 4/735; 0.5%; P = 0.274),
chronic pain (8/764; 1.0% versus 6/735; 0.8%; P = 0.642) and
other (14/764; 1.8% versus 12/735; 1.6%; P = 0.767).
The non-cirrhotic group lobar resection group comprised of
269 (18%) patients with 165 (61%) being performed with SH and
104 (39%) ER. Forty (3%) cirrhotic patients undergoing lobar
resections were also examined with 26 being SH and 14 ER. The
results of this analysis are presented in Table 2. These data confirm
when the extent of a resection is controlled. SH continues to
demonstrate advantages in decreased operative time, lower blood
loss and shorter hospital stay. Similar findings were present in the
cirrhotic group with the exception of shorter length of stay.
Further analysis of data did identify SH had a smaller pathological
margin on explanation than an electrosurgical dissection. The
incidence of recurrence between the SH and ER groups were not
significantly different (21/81:25.9% versus 11/65: 16.9%; P <
0.191). The median (range) time to recurrence was 13.0 (3–36)
versus 13.1 (5–55) months after a similar median follow-up
period of all patients [62.8 (13–106) months versus 54.5 (5–55)
months]. The most common site of cancer recurrence in the lobar
resections between the SH and ER were a second liver site (10/21
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versus 8/11; P = 0.173), lung (5/21 versus 2/11; P = 0.714), carci-
nomatosis (3/21 versus 1/11; P = 0.673) and the resection margin
(2/21 versus 1/11; P = 0.968). To assess the oncological integrity of
SH to ER all patients with cancer undergoing a major lobar resec-
tion were compared using a Kaplan–Meier analysis to examine the
overall survival and disease-free survival (Figs 1,2). No difference
in either overall patient survival or disease-free survival was iden-
tified. A multivariate analysis was then performed in all cancer
patients that required lobar or greater resections (Table 3). This
analysis identified smaller tumours as a continuous variable were
Table 1 Demographic, operative and outcome comparison of a stapler and electrosurgical hepatic resection
Stapler hepatectomy Electrosurgical resection P-value
Median age (years) 55.0 (18–88) 58.0 (18–91) 0.019
Female incidence 459/764 (60%) 390/735 (53%) 0.002
Median ASA 2.0 (1–4) 2.0 (1–4) 0.423
Median BMI 27.0 (17–33) 23.8 (19–47) 0.001
Cancer incidence 383/764 (37.1%) 378/735 (51.5%) 0.003
Cirrhosis incidence 112/764 (14.6%) 242/735 (33%) 0.001
Median tumour size (cm) 4.5 (0.5–50) 3.8 (0.5–25) 0.003
Incidence of lobar resection 107/764 (14%) 162/735 (22%) 0.001
Incidence of repeat resections 11/764 (1.4%) 9/735 (1.2%) 0.883
Median OR time (h) 2.6 (0.5–12.7) 3.1 (0.5–7.0) 0.001
Median EBL (ml) 100.0 (50–10,000) 200.0 (0–1500) 0.006
Incidence of transfusions 39/764 (5.1%) 65/735 (8.9%) 0.004
Incidence of conversion 12/764 (1.6%) 16/735 (2.2%) 0.432
Incidence of complications 121/764 (15.9%) 92/735 (12.6%) 0.067
Median length of stay (days) 3.0 (1–154) 7.0 (1–160) 0.003
Median margins (cm) 1.0 (0–9) 1.0 (0.1–6) 0.003
Overall incidence of tumour recurrence 81/764 (10.6%) 134/735 (18.3%) 0.001
BMI, body mass index; ASA, American Society of Anesthesiologists classification; EBL, estimated blood loss; OR, operating room; LOS, length of
stay; R1, resection resulting in a microscopic positive margin.
All contnuous variables are presented as medians with ranges.
Table 2 Comparison of stapler (SH) and electrosurgical resection (ER) in equivalent sized lobar resections
Non-cirrhotic lobectomies Cirrhotic lobectomies
ER SH P-value ER SH P-value
No. of patients 104 165 26 14
Median BMI 23.5 (18–31) 28.0 (14–43) 0.001 23.6 (21–38) 29.0 (23–29) 0.091
Median ASA 2.0 (2–3) 3.0 (1–4) 0.593 2.0 (1–4) 3.0 (2–4) 0.922
Median age (years) 55.7 (18–83) 54.0 (18–91) 0.812 59.0 (35–78) 62.0 (41–87) 0.223
Incidence cancers 43/104 (41%) 71/165 (43%) 0.836 22/26 10/14 0.762
Median tumour size (cm) 6.5 (0.7–6.0) 7.0 (0.8–21) 0.752 4.7 (1–12) 5.5 (1–8) 0.873
Median EBL (ml) 400 (50–10,000) 150 (25–3000) 0.001 462 (100–3500) 150 (25–500) 0.023
Median OR time (min) 5.0 (2.7–12.0) 3.0 (0.5–12.2) 0.001 5.2 (3–9.1) 2.2 (1–5.8) 0.001
Incidence of transfusion 7/104 (7%) 15/165 (9%) 0.474 1/26 1/14 0.145
Median LOS (days) 8.0 (1–60) 3.0 (1–11) 0.0001 10.5 (6–30) 7.0 (2–8) 0.498
Incidence of complications 26/104 (25%) 36/165 (22)% 0.255 8/26 6/14 0.563
Median margin (cm) 1.5 (0–6) 1.0 (0–6.0) 0.062 1.8 (0.1–9.0) 2 (0.5–2.0) 0.753
Incidence of R1 resection 2/43 2/71 (2.9%) 0.988 0/22 0/10 1.000
90-day mortality 1/104 (1.0%) 2/165 (1.2%) 0.976 0/26 0/14 1.000
Incidence of cancer recurrence 8/43 18/71 (25%) 0.323 3/22 3/10 0.755
BMI, body mass index; ASA, American Society of Anesthesiologists classification; EBL, estimated blood loss; OR, operating room; LOS, length of
stay; R1, resection resulting in a microscopic positive margin.
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at a lower risk for recurrence, whereas the presence of larger
tumours, cirrhosis or the need for concomitant intra-abdominal
surgery were at the highest risk for tumour recurrence.
The median disposable expense differential between SH and ER
was $3200 per patient; however, SH reduced the median operative
room utilization by 0.5 h (cost of $158/minute) for a median cost
savings of $4740. When all the operative time savings were sub-
tracted from the disposable expenses the total operative cost with
SH resulted in $13 000 per patient cost savings.
Discussion
A hepatic resection has evolved over the past four decades from a
significantly morbid and often fatal operation, to a routine surgi-
cal procedure with reported mortality rates of less than 5%, per-
formed for both benign and malignant tumours of the liver.14–16
This dramatic change was achieved through improved knowledge
of intrahepatic vascular and biliary anatomy, and the introduction
of new surgical and anaesthetic techniques. A SH was first intro-
duced over 20 years ago as a novel technique for division of
vascular inflow and outflow pedicles.1–5 This technique was sub-
sequently modified to an ultrasound-guided intrahepatic portal
triad division to minimize dissection at the portal bifurcation. A
SH was frequently discussed but found little support in the
general hepatobiliary literature until the introduction of laparo-
scopic liver resection.13
Multiple studies have confirmed intra-operative blood loss and
post-operative transfusion requirements were predictors of post-
operative morbidity and mortality in liver surgery. Additional
data suggested transfusion requirements impacted the oncological
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Figure 1 (a) Overall patient survival for non-cirrhotic cancer patients
undergoing a lobar resection; P-log-rank = 0.29. (b) Overall disease-
free survival for non-cirrhotic cancer patients undergoing a lobar
resection; P-log rank = 0.118
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Figure 2 (a) Overall patient survival for cirrhotic cancer patients
undergoing a lobar resection; P-log rank = 0.12. (b) Overall disease-
free survival for cirrhotic cancer patients undergoing a lobar resec-
tion; P-log rank = 0.268
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outcomes of a hepatic resection for colorectal metastases and
hepatocellular cancer.17–19 Data from this study demonstrates in
this multi-institutional study that SH results in significantly
shorter operative times, with less blood loss and lower transfusion
requirements. These clinical outcomes confirmed the findings of
two prior studies performed by Schemmer et al. and Reddy
et al.5,6,20 To insure the validity of these observations, subset analy-
sis of only lobar resections confirmed SH resulted in shorter
operative times and lower blood loss. Oncologic data for cancer
lobectomies confirmed patient and disease survival were equiva-
lent between SH and ER. Seemingly in spite of smaller surgical
margins, SH resulted in equivalent oncological outcomes. With
early recognition of the importance of haemorrhage control,
several techniques for vascular control have been employed and
studied. The most commonly employed technique for vascular
control of the liver is intermittent inflow control, known as the
Pringle manoeuver. Intermittent inflow control is easy to perform
but has the challenge of time limitations and the risk of significant
remnant ischaemia and subsequent reperfusion injury. Two other
methods of vascular control for liver resection have been
employed: total vascular isolation (TVI) and selective vascular
isolation. TVI was first reported by the Mt. Sinai transplant group
where upper and lower caval control, as well as aortic and portal
inflow is employed. This technique proved effective, but is difficult
to perform and is seldom used in current liver surgery. The alter-
native technique was selective vascular isolation whose concept is
appealing, providing haemorrhage control without the risk of
remnant ischaemia or subsequent reperfusion injury. This tech-
nique was first described and employed by Longmire using the
clamp bearing his name. In a retrospective study performed by
Buell et al., selective vascular control was shown to provide supe-
rior outcomes to TVI and the Pringle manoeuver.21
A laparoscopic SH was the natural progression of selective vas-
cular control. The stapler employs haemorrhage control without
incurring remnant ischaemia. This study examines the use of SH
in the setting of a multi-institutional experience with a laparo-
scopic liver resection. However, present data suggests there is a
bias in the use of SH. Importantly is the recognition that SH is
more commonly employed in the United States. With this recog-
nized, and the cultural reality of Asian and European centres, there
is a clear expectation that ER employed by the same centres would
result in a significantly longer hospital stay. Reddy et al. similar to
the current series experienced with SH identified this technique
was more frequently employed in female patients, patients with
benign tumors, and in the setting of non-cirrhotic livers.20 Inter-
estingly, this present study supports that, unlike previously
reported series, SH is utilized for larger tumours, and more fre-
quently for major hepatectomies than ER.21–28 In spite of what
might be perceived as more complex resections, the mean opera-
tive times, blood loss and transfusion requirements remained less
than that of the ER group. Conversion to open surgical procedures
was similar in both the SH and ER groups. SH patients did expe-
rience a trend towards a higher incidence of post-operative com-
plications, including bile leak, than in the ER group. The bile leak
rate in this series was less than that previously reported by Schem-
mer et al. or Reddy et al. of 8% and 12%, respectively.5,6,20
Lastly, the oncological integrity of this technique must be
addressed. SH provides a smaller pathological margin than the
electrosurgical technique. In spite of this finding, neither a
Kaplan–Meier analysis nor a multivariate regression analysis iden-
tified SH as a risk factor for tumour recurrence. This would
suggest that this pathological margin may not reflect an actual
margin. SH requires significant compression of the liver paren-
chyma and destruction of surrounding hepatic tissue. This
mechanical compression may in fact result in tissue destruction,
falsely altering the pathological margin. In spite of the salutary
benefits of SH, several significant shortfalls exist. The first is the
existence of a significant learning curve associated with the use of
the two principle stapling devices and development of a decision
algorithm for the amount and type of tissue placed into the
stapler. Each stapler has several important mechanical character-
istics including the staple formationmechanism, aperture gap and
the necessary compression pressures. Inappropriate attempts at
vascular division can led to immediate or delayed staple line dis-
ruption. Staple disruption of the hepatic or portal vein can result
in a massive haemorrhage with the risk of an air embolism. In
spite of this risk of stapler disruption, if SH is carried out in a
correct manner the incidence of these events are rare. The second
shortfall is the cost of SH. Significant criticism has been has been
focused on this fact. Analysis of cost data shows the cost of staplers
and a hand assist device in our cohort was $3200. When cost was
adjusted for a reduction in utilized operating room time, the
operative cost confirmed a $13 000 savings. Analysis of hospitali-
zation cost was felt to be inappropriate because of the significant
cultural variations in hospitalization expectations.
SH appears to provide several significant intra-operative advan-
tages over ES including a shorter operative time and diminished
blood loss. SHwhen used correctly has a similar safety and efficacy
Table 3 Multivariate analysis of factors affecting cancer recurrence
Variable Hazard ratio Hazard ratio
95% confidence levels
P-value
Tumour size 0.965 0.935 0.997 0.033
Absence of cirrhosis 0.561 0.316 0.997 0.049
Transfusion 0.540 0.311 0.936 0.028
Concomitant surgery 1.350 0.730 2.496 0.339
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profile to ES. Concerns over smaller resection margins appear to
be unfounded, but warrant further investigation. Cost analysis
appears to find disparaging comments over cost unwarranted.
This study supports SH as a safe and efficacious technique, but
notes surgeons should employ the technique with which they are
most comfortable.
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